BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $911,836 | -19.4% | 24,161 | -2.7% | 0.41% | -12.5% |
| Q2 2023 | $1,131,255 | +9.4% | 24,830 | -2.6% | 0.47% | +4.2% |
| Q1 2023 | $1,034,483 | -22.3% | 25,505 | -2.3% | 0.45% | -26.3% |
| Q4 2022 | $1,330,572 | -8.8% | 26,105 | -3.7% | 0.61% | -16.4% |
| Q3 2022 | $1,459,000 | -21.1% | 27,105 | -5.9% | 0.73% | -14.4% |
| Q2 2022 | $1,850,000 | -17.1% | 28,815 | +0.2% | 0.86% | -6.2% |
| Q1 2022 | $2,231,000 | -14.1% | 28,765 | -4.9% | 0.91% | -12.5% |
| Q4 2021 | $2,596,000 | +11.6% | 30,239 | +4.6% | 1.04% | +0.6% |
| Q3 2021 | $2,326,000 | -5.0% | 28,916 | -4.9% | 1.04% | -4.1% |
| Q2 2021 | $2,448,000 | -10.7% | 30,407 | -6.5% | 1.08% | -15.0% |
| Q1 2021 | $2,742,000 | +4.9% | 32,517 | -0.2% | 1.27% | -4.9% |
| Q4 2020 | $2,613,000 | -1.4% | 32,567 | -1.2% | 1.34% | -8.3% |
| Q3 2020 | $2,651,000 | -7.0% | 32,967 | -0.5% | 1.46% | -6.8% |
| Q2 2020 | $2,852,000 | -4.2% | 33,117 | -9.7% | 1.56% | -16.4% |
| Q1 2020 | $2,977,000 | -52.5% | 36,667 | -49.9% | 1.87% | +26.2% |
| Q4 2019 | $6,264,000 | +97.0% | 73,234 | +101.5% | 1.48% | -4.1% |
| Q3 2019 | $3,179,000 | +21.2% | 36,342 | +13.5% | 1.55% | +15.7% |
| Q2 2019 | $2,623,000 | -0.5% | 32,032 | -1.2% | 1.34% | -2.5% |
| Q1 2019 | $2,637,000 | +21.6% | 32,432 | -1.5% | 1.37% | +7.1% |
| Q4 2018 | $2,168,000 | -15.5% | 32,932 | -1.1% | 1.28% | -3.4% |
| Q3 2018 | $2,565,000 | +0.2% | 33,282 | -4.0% | 1.32% | -5.6% |
| Q2 2018 | $2,559,000 | +7.9% | 34,657 | -4.9% | 1.40% | +4.8% |
| Q1 2018 | $2,371,000 | -0.6% | 36,457 | -1.2% | 1.34% | +3.8% |
| Q4 2017 | $2,385,000 | +1.7% | 36,907 | -1.2% | 1.29% | -2.1% |
| Q3 2017 | $2,344,000 | +1.7% | 37,357 | -1.8% | 1.32% | -1.4% |
| Q2 2017 | $2,304,000 | +11.7% | 38,057 | -4.4% | 1.34% | +12.1% |
| Q1 2017 | $2,063,000 | +14.9% | 39,791 | -1.7% | 1.19% | +11.0% |
| Q4 2016 | $1,795,000 | -11.4% | 40,491 | -4.9% | 1.08% | -13.9% |
| Q3 2016 | $2,027,000 | -2.5% | 42,591 | -7.4% | 1.25% | -3.5% |
| Q2 2016 | $2,079,000 | +1.8% | 45,991 | -7.5% | 1.29% | +1.1% |
| Q1 2016 | $2,043,000 | +2.2% | 49,735 | -5.1% | 1.28% | -1.7% |
| Q4 2015 | $2,000,000 | +13.1% | 52,435 | -2.6% | 1.30% | +3.4% |
| Q3 2015 | $1,769,000 | -47.4% | 53,837 | +12.0% | 1.26% | -42.3% |
| Q2 2015 | $3,362,000 | +7.3% | 48,074 | +5.1% | 2.18% | +8.2% |
| Q1 2015 | $3,132,000 | -4.1% | 45,724 | +2.6% | 2.02% | +2.5% |
| Q4 2014 | $3,267,000 | +5.3% | 44,574 | +3.1% | 1.97% | +5.9% |
| Q3 2014 | $3,102,000 | +9.5% | 43,224 | +10.3% | 1.86% | +9.8% |
| Q2 2014 | $2,832,000 | +4.7% | 39,172 | +6.5% | 1.69% | -0.2% |
| Q1 2014 | $2,706,000 | +4.2% | 36,785 | -1.5% | 1.70% | -0.1% |
| Q4 2013 | $2,597,000 | +10.0% | 37,335 | +3.9% | 1.70% | +3.8% |
| Q3 2013 | $2,360,000 | – | 35,935 | – | 1.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |